Active Not RecruitingNCT04801589
Sedation approaches for ventilated infants and children
About this title
Read the official source — NCT04801589Medication studyAges 44 weeks–11 yearsUnited StatesPTSD
Understand this study
Who could participate?
Listed age limits: 44 weeks to 11 years.
- Listed locations
- NashvilleSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 10, 2021
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 372
- Sponsor
- Vanderbilt University Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 44 Weeks to 11 Years
- Official registry ID
- NCT04801589
- Official title
Show the full official title
Maximizing Efficacy of Goal-Directed Sedation to Reduce Neurological Dysfunction in Mechanically Ventilated Infants and Children Study
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Nashville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Vanderbilt University Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Dexmedetomidine and Midazolam.
Who can participate?
Listed age limits: 44 weeks to 11 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
